SomaLogic, Inc.
SLGC · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $22,048 | $20,468 | $20,379 | $18,829 |
| % Growth | 7.7% | 0.4% | 8.2% | – |
| Cost of Goods Sold | $11,635 | $11,175 | $12,316 | $12,965 |
| Gross Profit | $10,413 | $9,293 | $8,063 | $5,864 |
| % Margin | 47.2% | 45.4% | 39.6% | 31.1% |
| R&D Expenses | $10,458 | $10,815 | $14,067 | $22,589 |
| G&A Expenses | $0 | $0 | $0 | $34,256 |
| SG&A Expenses | $23,880 | $29,573 | $34,189 | $37,756 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $3,500 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $34,338 | $40,388 | $48,256 | $60,345 |
| Operating Income | -$28,082 | -$31,095 | -$40,193 | -$54,481 |
| % Margin | -127.4% | -151.9% | -197.2% | -289.3% |
| Other Income/Exp. Net | $6,403 | $6,325 | $5,993 | $5,135 |
| Pre-Tax Income | -$21,679 | -$24,770 | -$34,200 | -$49,346 |
| Tax Expense | $478 | $2 | $2 | -$95 |
| Net Income | -$22,157 | -$24,772 | -$34,202 | -$49,251 |
| % Margin | -100.5% | -121% | -167.8% | -261.6% |
| EPS | -0.12 | -0.13 | -0.18 | -0.26 |
| % Growth | 7.7% | 27.8% | 30.8% | – |
| EPS Diluted | -0.12 | -0.13 | -0.18 | -0.26 |
| Weighted Avg Shares Out | 187,071 | 186,741 | 186,524 | 186,313 |
| Weighted Avg Shares Out Dil | 187,071 | 186,741 | 186,524 | 186,313 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,087 | $5,798 | $4,925 | $4,593 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,900 | $1,890 | -$1,068 | $4,593 |
| EBITDA | -$18,184 | -$29,732 | -$40,193 | -$49,888 |
| % Margin | -82.5% | -145.3% | -197.2% | -265% |